Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors

N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors

US Patent 8741921 · Granted Jun 3, 2014

Estimated economic value: $79,195,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of diagnosing and treating dry eye syndrome and compositions for treatin2025
Methods of diagnosing and treating dry eye syndrome and compositions for treatin2024
Methods of diagnosing and treating dry eye syndrome and compositions for treatin2023
Preparation method for fumaric acid pour point depressant for crude oil2022
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidaz2022
Presbyopia treatments2022
Phenyl urea derivatives as N-formyl peptide receptor modulators2022
Phenyl urea derivatives as n-formyl peptide receptor modulators2021
Alpha-2-adrenergic receptor agonists for treatment of presbyopia, visual glare, 2021
Sulfur derivatives as chemokine receptor modulators2021
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor l2021
Imidazole derivatives as formyl peptide receptor modulators2020